Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Golconda Gold Ltd. ("Golconda Gold" or the "Company") (TSX-V: GG; OTCQB: GGGOF) is pleased to announce the release of its financial results for the three and ...
CyberArk (NASDAQ: CYBR), the global leader in identity security, today announced that Chief Financial Officer (CFO) Josh Siegel will step down on January 1, 2025 and transition into an advisory role.
First Mining Gold Corp. is pleased to announce that an Independent Geotechnical and Tailings Review Board has been formally established for the Springpole Gold Project . First Mining's initiative in ...